J. Rifón

3.1k citations
60 papers · 1.5k indexed · h-index 18
Topics
Acute Myeloid Leukemia Research (11 papers)Chronic Lymphocytic Leukemia Research (9 papers)Lymphoma Diagnosis and Treatment (7 papers)
Journals
SHILAP Revista de lepidopterologíaBloodPLoS ONE
Partner nations
SpainFranceUnited States

In The Last Decade

J. Rifón

56 papers receiving 1.4k citations

Peers

J. Rifón
Comparison fields: 5 of 85
  • Molecular Biology 641
  • Hematology 515
  • Genetics 361
  • Oncology 316
  • Cancer Research 287
Replace Ryuichi Kamiyama with:
Ryuichi Kamiyama Japan
Rajko Kušec Croatia
Vanessa Bolejack United States
Catherine C. Coombs United States
G Tobelem France
Po Dunn Taiwan
Seongseok Yun United States
Leonard T. Heffner United States
Ming‐Chung Kuo Taiwan
Álvaro Aguayo Mexico
J. Rifón relative to Ryuichi Kamiyama Japan Ryuichi Kamiyama's profile →
Citations per field
00.5×1.5×2.5×
Ryuichi Kamiyama · 1×
Citations per year

Countries citing papers authored by J. Rifón

Since Specialization
Citations

This map shows the geographic impact of J. Rifón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Rifón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Rifón more than expected).

Fields of papers citing papers by J. Rifón

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Rifón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Rifón. The network helps show where J. Rifón may publish in the future.

Co-authorship network of co-authors of J. Rifón

This figure shows the co-authorship network connecting the top 25 collaborators of J. Rifón. A scholar is included among the top collaborators of J. Rifón based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Rifón. J. Rifón is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 4
2 24
3 5
4 28
5 2
6 18
7 2
8 47
9 136
10 242
11 9
12 5
13 16
14 28
15 6
16 3
17 14
18 4
19 48
20
[Coagulation inhibitors in patients with neoplasms].
2

About J. Rifón

J. Rifón is a scholar working on Hematology, Genetics and Oncology, having authored 60 papers that have together received 1.5k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (11 papers), Chronic Lymphocytic Leukemia Research (9 papers) and Lymphoma Diagnosis and Treatment (7 papers). The work is most often cited by research in Hematology (515 citations), Genetics (361 citations) and Cancer Research (287 citations). J. Rifón has collaborated with scholars based in Spain, France and United States. Frequent co-authors include Felipe Prósper, Marı́a José Calasanz, José A. Páramo, Eduardo Rocha, Xabier Agirre, José I. Martı́n-Subero, Eva Bandrés, José Román‐Gómez, Edurne San José‐Eneriz and Enrique J. Andreu. Their work appears in journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026